SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-066108
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:28
Documents
13
Period of Report
2024-08-06
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210771-8k_onconetix.htm   iXBRL 8-K 31460
  Complete submission text file 0001213900-24-066108.txt   207223

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20240806.xsd EX-101.SCH 3042
3 XBRL LABEL FILE onco-20240806_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE onco-20240806_pre.xml EX-101.PRE 22377
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0210771-8k_onconetix_htm.xml XML 3795
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 241183569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)